AstraZenecaPlc'sCOVID-19vaccineiseffectiveagainstDelta and Kappavariants, which were firstidentifiedinIndia, the company said on Tuesday, citing a study.
The study by the Oxford University investigated the ability of monoclonal antibodies in blood from recovered people and from those vaccinated to neutralize the Delta and Kappavariants, the statement said.
Also Read |Socialists are 'terrorists', describes US military training manual
Last week, an analysis by the Public Health England (PHE) showed thatvaccines made by Pfizer Inc andAstraZenecaoffer high protection of more than 90%againsthospitalization from the Delta variant.
The latest Oxford study results are built on the recent analysis by PHE, the company said.
The Delta variant is becoming the globally dominant version of the disease, the World Health Organization's chief scientist said on Friday.